Hedge Fund - Soleus Capital
Nurix Therapeutics Inc. (NRIX)
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2026 - Q2 (2026-06-30) | $35,544,854 | 1.22% | 1,465,163 | $17.03 |
| 2 | 2026 - Q1 (2026-03-31) | $14,541,527 | 0.59% | 938,163 | $16.58 |
| 3 | 2025 - Q4 (2025-12-31) | $23,131,904 | 0.85% | 1,219,394 | $14.37 |
| 4 | 2025 - Q3 (2025-09-30) | $22,386,977 | 1.13% | 2,422,833 | $10.38 |
| 5 | 2025 - Q2 (2025-06-30) | $27,596,068 | 1.83% | 2,422,833 | $10.81 |
| 6 | 2025 - Q1 (2025-03-31) | $28,783,256 | 2.07% | 2,422,833 | $16.73 |
| 7 | 2024 - Q4 (2024-12-31) | $39,617,374 | 2.48% | 2,102,833 | $22.92 |
| 8 | 2024 - Q3 (2024-09-30) | $23,949,290 | 1.85% | 1,065,834 | $22.65 |
| 9 | 2024 - Q2 (2024-06-30) | $42,906,967 | 3.78% | 2,055,916 | $15.57 |
| 10 | 2024 - Q1 (2024-03-31) | $16,390,500 | 1.21% | 1,115,000 | $10.76 |
| 11 | 2023 - Q4 (2023-12-31) | $1,475,760 | 0.16% | 143,000 | $6.85 |
| 12 | 2023 - Q3 (2023-09-30) | $6,398,040 | 0.59% | 814,000 | $9.13 |
| 13 | 2022 - Q4 (2022-12-31) | $0 | 0% | 0 | $12.06 |
| 14 | 2022 - Q3 (2022-09-30) | $6,569,000 | 0.89% | 504,144 | $15.83 |
| 15 | 2022 - Q2 (2022-06-30) | $12,600,000 | 1.96% | 994,492 | $11.33 |
| 16 | 2022 - Q1 (2022-03-31) | $14,173,000 | 1.82% | 1,011,638 | $17.75 |
| 17 | 2021 - Q4 (2021-12-31) | $21,517,000 | 2.15% | 743,238 | $30.32 |
| 18 | 2021 - Q3 (2021-09-30) | $7,906,000 | 1.23% | 263,900 | $30.86 |
The displayed share prices are average quarterly stock market prices.
Hedge Fund Resource Center